<html>
<head>PUBMED IDs for UCHL5</head>
<body bgcolor='#C5F0F2'><h1>UCHL5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21837707/'>Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.</a> March 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21837697/'>Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer.</a> December 30  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22057347/'>Inhibition of proteasome deubiquitinating activity as a new cancer therapy.</a> February 3  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24319254/'>A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.</a> March 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24348898/'>Identification of unstable network modules reveals disease modules associated with the progression of Alzheimer's disease.</a> July 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24465953/'>Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth.</a> October 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25193854/'>Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms.</a> August 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25691154/'>Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenstr√∂m macroglobulinaemia tumour cells.</a> July 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27256563/'>Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors.</a> June 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27256532/'>[Inhibitory effect of quercetin on the biofilm formation of Streptococcus mutans].</a> January 25  2016<br></body></html>
